Global Antiviral Drugs Market (By Type, Application & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

Global Antiviral Drugs Market (By Type, Application & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

The global antiviral drugs market is expected to reach US$70.95 billion in 2024, increasing at a CAGR of 2.10%, for the duration of 2020-2024. The factors such as, increasing prevalence of HIV infections, upswing in international tourism, growth in geriatric population, increasing pharmaceutical R&D spending, rapid urbanization, upsurge in healthcare spending and growing awareness about various viral diseases are expected to drive the growth of the market. However, the market growth would be challenged by high cost involves in drug development, threats associated with drug counterfeiting and stringent government regulations. A few notable trends may include accelerating growth rate of infectious diseases, increasing focus on telehealth, growth in pharmaceutical Merger & acquisitions and emergence of new infectious diseases.

The global antiviral drugs market is fragmented into branded drugs and generic drugs. Branded drugs dominate the market owing to the increased levels of trust and reliability associated with branded pharmaceutical companies among customers. However, generic drugs are also gaining widespread popularity among customers due to the low cost factor, which is likely to raise its share in global market in coming years.

The fastest growing regional market was North America owing to the presence of key players in the region, availability of sophisticated healthcare infrastructure and increasing awareness of viral diseases among people. Whereas, Europe and Asia Pacific also contributed to significant shares in the global market due to the factors such as increase in patient pool of various infectious diseases and rise in the acceptance of generic drugs. However, the sudden outbreak of COVID-19 has caused a major disruption all across the world, which is leading to the massive demand for antiviral drugs for the management of infected coronavirus patients, providing the growth opportunity to the market globally.

Scope of the report:

The report provides a comprehensive analysis of the global antiviral drugs market.

The major regional markets (North America, Europe, Asia-Pacific Middle East & Africa) have been analyzed.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The competitive landscape of the market, along with the company profiles of leading players (Johnson & Johnson, Merck & Co., AbbVie Inc., Bristol-Myer Squibb, Gilead Sciences and Cipla) are also presented in detail.

Key Target Audience:

Antiviral Drugs Manufacturers

Pharmaceuticals and Biopharmaceutical Firms

End Users (Hospitals, Clinics, Pharmacies, Drugs Stores, etc.)

Investment Banks

Healthcare and Medical Consultants

Government Bodies & Regulating Authorities


1. Overview
1.1 Introduction
1.2 Viral Life Cycle
Table 1: Viral Life Cycle
1.3 Antiviral Agents
Table 2: Antiviral Agents For Different Indications
1.4 Development of Antiviral Drugs
Table 3: Development of Antiviral Drugs
1.5 Some Major Antiviral Compounds
Table 4: Some Major Antiviral Compounds Developed and Approved for Use in Humans
2. Impact of COVID-19
2.1 Rise in COVID-19 Death Toll
Table 5: Global COVID-19 Confirmed Deaths
2.2 Growth in Government Spending on Healthcare
Table 6: Global Government Share on Health Spending (2019-2024)
2.3 COVID-19 Antiviral Candidate Drugs in Trial
Table 7: COVID-19 Antiviral Candidate Drugs in Phase III-IV Trials
2.4 Regional Impact
3. Remdesivir and COVID-19
3.1 Remdesivir
3.2 Major Clinical Studies of Remdesivir
Table 8: Major Clinical Studies of Remdesivir
3.3 Emergency Use of Remdesivir
4. Global Market Analysis
4.1 Global Antiviral Drugs Market by Value
Table 9: Global Antiviral Drugs Market by Value (2015-2019)
4.2 Global Antiviral Drugs Market Forecast by Value
Table 10: Global Antiviral Drugs Market Forecast by Value (2020-2024)
4.3 Global Antiviral Drugs Market Value by Type
Table 11: Global Antiviral Drugs Market Value by Type (2019)
4.3.1 Global Branded Antiviral Drugs Market by Value
Table 12: Global Branded Antiviral Drugs Market by Value (2015-2019)
4.3.2 Global Branded Antiviral Drugs Market Forecast by Value
Table 13: Global Branded Antiviral Drugs Market Forecast by Value (2020-2024)
4.3.3 Global Generic Antiviral Drugs Market by Value
Table 14: Global Generic Antiviral Drugs Market by Value (2015-2019)
4.3.4 Global Generic Antiviral Drugs Market Forecast by Value
Table 15: Global Generic Antiviral Drugs Market Forecast by Value (2020-2024)
4.4 Global Antiviral Drugs Market Value by Application
Table 16: Global Antiviral Drugs Market Value by Application (2019)
4.4.1 Global Hepatitis Antiviral Drugs Market by Value
Table 17: Global Hepatitis Antiviral Drugs Market by Value (2015-2019)
4.4.2 Global Hepatitis Antiviral Drugs Market Forecast by Value
Table 18: Global Hepatitis Antiviral Drugs Market Forecast by Value (2020-2024)
4.4.3 Global HIV Antiviral Drugs Market by Value
Table 19: Global HIV Antiviral Drugs Market by Value (2015-2019)
4.4.4 Global HIV Antiviral Drugs Market Forecast by Value
Table 20: Global HIV Antiviral Drugs Market Forecast by Value (2020-2024)
4.4.5 Global Influenza Antiviral Drugs Market by Value
Table 21: Global Influenza Antiviral Drugs Market by Value (2015-2019)
4.4.6 Global Influenza Antiviral Drugs Market Forecast by Value
Table 22: Global Influenza Antiviral Drugs Market Forecast by Value (2020-2024)
4.4.7 Global Herpes Antiviral Drugs Market by Value
Table 23: Global Herpes Antiviral Drugs Market by Value (2015-2019)
4.4.8 Global Herpes Antiviral Drugs Market Forecast by Value
Table 24: Global Herpes Antiviral Drugs Market Forecast by Value (2020-2024)
4.5 Global Antiviral Drugs Market Value by Regions
Table 25: Global Antiviral Drugs Market Value by Regions (2019)
5. Regional Market Analysis
5.1 North America
5.1.1 North America Antiviral Drugs Market by Value
Table 26: North America Antiviral Drugs Market by Value (2015-2019)
5.1.2 North America Antiviral Drugs Market Forecast by Value
Table 27: North America Antiviral Drugs Market Forecast by Value (2020-2024)
5.1.3 North America Antiviral Drugs Market by Region
Table 28: North America Antiviral Drugs Market by Region (2019)
5.1.4 The U.S. Antiviral Drugs Market by Value
Table 29: The U.S. Antiviral Drugs Market by Value (2015-2019)
5.1.5 The U.S. Antiviral Drugs Market Forecast by Value
Table 30: The U.S. Antiviral Drugs Market Forecast by Value (2020-2024)
5.1.6 The U.S. Antiviral Drugs Market by Type
Table 31: The U.S. Antiviral Drugs Market by Type (2019)
5.1.7 The U.S. Branded Antiviral Drugs Market by Value
Table 32: The U.S. Branded Antiviral Drugs Market by Value (2015-2019)
5.1.8 The U.S. Branded Antiviral Drugs Market Forecast by Value
Table 33: The U.S. Branded Antiviral Drugs Market Forecast by Value (2020-2024)
5.1.9 The U.S. Generic Antiviral Drugs Market by Value
Table 34: The U.S. Generic Antiviral Drugs Market by Value (2015-2019)
5.1.10 The U.S. Generic Antiviral Drugs Market Forecast by Value
Table 35: The U.S. Generic Antiviral Drugs Market Forecast by Value (2020-2024)
5.2 Europe
5.2.1 Europe Antiviral Drugs Market by Value
Table 36: Europe Antiviral Drugs Market by Value (2015-2019)
5.2.2 Europe Antiviral Drugs Market Forecast by Value
Table 37: Europe Antiviral Drugs Market Forecast by Value (2020-2024)
5.3 Asia Pacific
5.3.1 Asia Pacific Antiviral Drugs Market by Value
Table 38: Asia Pacific Antiviral Drugs Market by Value (2015-2019)
5.3.2 Asia Pacific Antiviral Drugs Market Forecast by Value
Table 39: Asia Pacific Antiviral Drugs Market Forecast by Value (2020-2024)
5.4 Middle East & Africa
5.4.1 Middle East & Africa Antiviral Drugs Market by Value
Table 40: Middle East & Africa Antiviral Drugs Market by Value (2015-2019)
5.4.2 Middle East & Africa Antiviral Drugs Market Forecast by Value
Table 41: Middle East & Africa Antiviral Drugs Market Forecast by Value (2020-2024)
5.5 Latin America
5.5.1 Latin America Antiviral Drugs Market by Value
Table 42: Latin America Antiviral Drugs Market by Value (2015-2019)
5.5.2 Latin America Antiviral Drugs Market Forecast by Value
Table 43: Latin America Antiviral Drugs Market Forecast by Value (2020-2024)
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Increasing Prevalence of HIV Infections
Table 44: Global HIV Infected Population (2015-2019)
6.1.2 Upswing in International Tourism
Table 45: Global International Tourist Arrivals (2015-2019)
6.1.3 Growth in Geriatric Population
Table 46: Global Geriatric Population – Age 65 and Above (2015-2019)
6.1.4 Increasing Pharmaceutical R&D Spending
Table 47: Global Pharmaceutical R&D Spending (2015-2019)
6.1.5 Rapid Urbanization
Table 48: Global Urban Population (2015-2019)
6.1.6 Upsurge in Healthcare Expenditures
Table 49: Global Healthcare Expenditure Per Capita (2015-2019)
6.1.7 Growing Awareness About Various Viral infections and Diseases
6.2 Key Trends and Developments
6.2.1 Accelerating Growth Rates of Infectious Diseases
Table 50: Global Growth Rate of Infectious Diseases Forecast (2017-2022)
6.2.2 Increasing Focus on Telehealth
Table 51: Global Telehealth Patient Population (2015-2019)
6.2.3 Growth in Pharmaceutical and Biotech Merger & Acquisition
Table 52: Global Pharmaceutical and Biotech M&A (2015-2019)
6.2.4 Emergence of Various Pandemic Diseases
6.3 Challenges
6.3.1 High Cost Involved in Drug Development
6.3.2 Threats Associated with Drugs Counterfeiting
6.3.3 Stringent Government Regulations
7. Competitive Landscape
7.1 Global Market
7.1.1 Key Players – Revenue Comparison
Table 53: Key Players – Revenue Comparison (2019)
7.1.2 Key Players – R&D Expenditure Comparison
Table 54: Key Players – R&D Expenditure Comparison (2019)
7.1.3 Key Players – Market Capitalization Comparison
Table 55: Key Players – Market Capitalization Comparison (2020)
8. Company Profiles
8.1 Johnson & Johnson
8.1.1 Business Overview
8.1.2 Financial Overview
Table 56: Johnson & Johnson Total Sales and Net Earnings (2015-2019)
Table 57: Johnson & Johnson Total Sales by Segments (2019)
Table 58: Johnson & Johnson Total Sales by Regions (2019)
8.1.3 Business Strategies
8.2 Merck and Co.
8.2.1 Business Overview
8.2.2 Financial Overview
Table 59: Merck and Co. Sales and Net Income (2015-2019)
Table 60: Merck and Co. Sales by Segments (2019)
Table 61: Merck and Co. Sales by Regions (2019)
8.2.3 Business Strategies
8.3 AbbVie Inc.
8.3.1 Business Overview
8.3.2 Financial Overview
Table 62: AbbVie Inc. Net Revenue and Net Earnings (2015-2019)
Table 63: AbbVie Inc. Net Revenue by Product (2019)
Table 64: AbbVie Inc. Net Revenue by Regions (2019)
8.3.3 Business Strategies
8.4 Bristol-Myers Squibb
8.4.1 Business Overview
8.4.2 Financial Overview
Table 65: Bristol-Myers Squibb Total Revenue and Net Earnings (2015-2019)
Table 66: Bristol-Myers Squibb Total Revenue by Operations (2019)
Table 67: Bristol-Myers Squibb Total Revenue by Regions (2019)
8.4.3 Business Strategies
8.5 Gilead Sciences
8.5.1 Business Overview
8.5.2 Financial Overview
Table 68: Gilead Sciences Total Revenue and Net Income (2015-2019)
Table 69: Gilead Sciences Total Revenue by Operations (2019)
Table 70: Gilead Sciences Total Revenue by Regions (2019)
8.5.3 Business Strategies
8.6 Cipla
8.6.1 Business Overview
8.6.2 Financial Overview
Table 71: Cipla Revenue and Profit (2015-2019)
Table 72: Cipla Revenue by Segments (2019)
Table 73: Cipla Revenue by Regions (2019)
8.6.3 Business Strategies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook